Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis (CL-010)

Clinical trial NCT00944021 · COMPLETED

Trial details

NCT number: NCT00944021
Sponsor: Global Alliance for TB Drug Development
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pulmonary Tuberculosis

Start date: 2009-08-01
Primary completion: 2010-01-01
Enrollment: 69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.